"Antibody Specificity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
| Descriptor ID |
D000918
|
| MeSH Number(s) |
G12.100
|
| Concept/Terms |
Antibody Specificity- Antibody Specificity
- Antibody Specificities
- Specificities, Antibody
- Specificity, Antibody
|
Below are MeSH descriptors whose meaning is more general than "Antibody Specificity".
Below are MeSH descriptors whose meaning is more specific than "Antibody Specificity".
This graph shows the total number of publications written about "Antibody Specificity" by people in this website by year, and whether "Antibody Specificity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 5 | 6 |
| 2005 | 1 | 3 | 4 |
| 2006 | 1 | 6 | 7 |
| 2007 | 0 | 3 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 3 | 3 |
| 2017 | 3 | 27 | 30 |
| 2018 | 7 | 18 | 25 |
| 2019 | 1 | 3 | 4 |
| 2020 | 1 | 13 | 14 |
| 2021 | 2 | 18 | 20 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibody Specificity" by people in Profiles.
-
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection. J Infect Dis. 2021 11 16; 224(9):1489-1499.
-
Sensitive detection of anti-spike antibodies enables improved understanding of SARS-CoV-2 pathogenesis. Immunology. 2021 09; 164(1):1-2.
-
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 08 11; 12(1):4864.
-
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding. Biochem Biophys Res Commun. 2021 09 24; 571:152-158.
-
Early antibody responses associated with survival in COVID19 patients. PLoS Pathog. 2021 07; 17(7):e1009766.
-
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence. PLoS Pathog. 2021 07; 17(7):e1009761.
-
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity? J Autoimmun. 2021 09; 123:102706.
-
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern. JCI Insight. 2021 07 08; 6(13).
-
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants. Immunity. 2021 08 10; 54(8):1841-1852.e4.
-
A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination. Blood. 2021 07 01; 137(26):3656-3659.